Pharmacokinetics of topically applied ciprofloxacin in tears of mesocephalic and brachycephalic dogs
- 8 January 2008
- journal article
- Published by Wiley in Veterinary Ophthalmology
- Vol. 11 (1), 7-10
- https://doi.org/10.1111/j.1463-5224.2007.00591.x
Abstract
To evaluate the pharmacokinetics of ophthalmic ciprofloxacin in the tear film of normal mesocephalic and brachycephalic dogs. Twenty mesocephalic dogs and 15 brachycephalic dogs. Thirty-five microliters of ciprofloxacin were placed on the cornea of both eyes of each dog. Five brachycephalic dogs were used twice. A tear-test strip placed in the ventral cul de sac for 30 s was used to obtain samples. The tear film of each eye was sampled once at eight time-points post administration, resulting in five samples at each time-point. Samples were evaluated using high performance liquid chromatography. Data from the two skull types were compared using the unpaired two-tailed t-test. The mean concentration of ciprofloxacin in the tears of mesocephalic dogs was 192.8 +/- 269.97, 140.6 +/- 91.06, 56.60 +/- 28.47, 13.6 +/- 6.3, 43.25 +/- 59.71, 16.6 +/- 10.62, 15.6 +/- 13.16 and 6.25 +/- 9.84 microg/g at 5, 10, 15, 30 min and 1, 2, 4 and 6 h, respectively. The mean concentration of ciprofloxacin in the tears of brachycephalic dogs was 272.6 +/- 106.21, 144.4 +/- 142.32, 131.2 +/- 147.07, 75 +/- 80.07, 40.8 +/- 30.35, 35 +/- 21.98, 52.75 +/- 51.87 and 8.6 +/- 12.10 microg/g at 5, 10, 15, 30 min and 1, 2, 4 and 6 h, respectively. There was no statistical difference in tear concentration at any time-point between skull types. Topical application of ciprofloxacin resulted in a mean tear concentration of ciprofloxacin that remained above the MIC(90) levels for most pathogenic bacteria for 6 h in normal mesocephalic and brachycephalic dogs.Keywords
This publication has 20 references indexed in Scilit:
- Pharmacokinetics of topically applied ciprofloxacin in equine tearsVeterinary Ophthalmology, 2007
- In vitro fluoroquinolone susceptibility of Pseudomonas aeruginosa isolates from dogs with ulcerative keratitisAmerican Journal of Veterinary Research, 2007
- Evaluation of clinical characteristics and bacterial isolates in dogs with bacterial keratitis: 97 cases (1993–2003)Journal of the American Veterinary Medical Association, 2006
- Ciprofloxacin and ofloxacin aqueous humor concentrations after topical administration in dogs undergoing cataract surgeryVeterinary Ophthalmology, 2005
- Comparison of Tear Sampling Techniques for Pharmacokinetic Analysis: Ofloxacin Concentrations in Rabbit Tears after Sampling with Schirmer Tear Strips, Capillary Tubes, or Surgical SpongesJournal of Ocular Pharmacology and Therapeutics, 2000
- Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration.British Journal of Ophthalmology, 1995
- Tear Concentrations of Topically Applied CiprofloxacinCornea, 1994
- Ofloxacin in Human Serum, Urine, and Tear Film After Topical ApplicationCornea, 1992
- Biomicroscopy of the tear film: the tear film of the pekingese dogPublished by Wiley ,1989